CN107375697B - 一种具有润肠通便的复方制剂及其制备方法和应用 - Google Patents
一种具有润肠通便的复方制剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN107375697B CN107375697B CN201710764720.9A CN201710764720A CN107375697B CN 107375697 B CN107375697 B CN 107375697B CN 201710764720 A CN201710764720 A CN 201710764720A CN 107375697 B CN107375697 B CN 107375697B
- Authority
- CN
- China
- Prior art keywords
- parts
- filtrate
- preparation
- compound preparation
- relaxing bowel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 88
- 230000002040 relaxant effect Effects 0.000 title claims abstract description 57
- 150000001875 compounds Chemical class 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 claims abstract description 58
- 238000002156 mixing Methods 0.000 claims abstract description 49
- 230000000694 effects Effects 0.000 claims abstract description 40
- 244000017020 Ipomoea batatas Species 0.000 claims abstract description 23
- 235000002678 Ipomoea batatas Nutrition 0.000 claims abstract description 23
- 244000157072 Hylocereus undatus Species 0.000 claims abstract description 21
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 20
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 20
- 244000268590 Euryale ferox Species 0.000 claims abstract description 20
- 241000222336 Ganoderma Species 0.000 claims abstract description 20
- 235000018481 Hylocereus undatus Nutrition 0.000 claims abstract description 20
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 19
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 15
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 15
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 15
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 15
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 15
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 13
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 13
- 240000004507 Abelmoschus esculentus Species 0.000 claims abstract description 6
- 240000005528 Arctium lappa Species 0.000 claims abstract 5
- 239000000706 filtrate Substances 0.000 claims description 92
- 239000000843 powder Substances 0.000 claims description 81
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- 239000000919 ceramic Substances 0.000 claims description 40
- 239000002994 raw material Substances 0.000 claims description 36
- 238000001914 filtration Methods 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 239000004382 Amylase Substances 0.000 claims description 26
- 102000013142 Amylases Human genes 0.000 claims description 26
- 108010065511 Amylases Proteins 0.000 claims description 26
- 235000019418 amylase Nutrition 0.000 claims description 26
- 108010059892 Cellulase Proteins 0.000 claims description 25
- 108091005804 Peptidases Proteins 0.000 claims description 25
- 239000004365 Protease Substances 0.000 claims description 25
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 25
- 229940106157 cellulase Drugs 0.000 claims description 25
- 238000000855 fermentation Methods 0.000 claims description 22
- 230000004151 fermentation Effects 0.000 claims description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 21
- 229930006000 Sucrose Natural products 0.000 claims description 21
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 21
- 239000005720 sucrose Substances 0.000 claims description 21
- 238000010298 pulverizing process Methods 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 17
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 229940088598 enzyme Drugs 0.000 claims description 15
- 108010059820 Polygalacturonase Proteins 0.000 claims description 14
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 14
- 239000011148 porous material Substances 0.000 claims description 14
- 238000009489 vacuum treatment Methods 0.000 claims description 14
- 238000001694 spray drying Methods 0.000 claims description 12
- 238000005507 spraying Methods 0.000 claims description 12
- 238000004140 cleaning Methods 0.000 claims description 11
- 238000007873 sieving Methods 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 9
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 238000002474 experimental method Methods 0.000 abstract description 24
- 230000036541 health Effects 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000000857 drug effect Effects 0.000 abstract description 3
- 235000019640 taste Nutrition 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 25
- 241000699670 Mus sp. Species 0.000 description 21
- 241001075517 Abelmoschus Species 0.000 description 16
- 241000208843 Arctium Species 0.000 description 14
- 241000186660 Lactobacillus Species 0.000 description 13
- 229940039696 lactobacillus Drugs 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 206010010774 Constipation Diseases 0.000 description 10
- 210000000813 small intestine Anatomy 0.000 description 9
- 210000003608 fece Anatomy 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000013642 negative control Substances 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 230000013872 defecation Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 240000008397 Ganoderma lucidum Species 0.000 description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000008141 laxative Substances 0.000 description 3
- 229940125722 laxative agent Drugs 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000209477 Nymphaeaceae Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- -1 compound diphenoxylate Chemical class 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229960004192 diphenoxylate Drugs 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 244000294263 Arctium minus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 208000027932 Collagen disease Diseases 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 235000002723 Dioscorea alata Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 235000010837 Echinocereus enneacanthus subsp brevispinus Nutrition 0.000 description 1
- 235000006850 Echinocereus enneacanthus var dubius Nutrition 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001141 propulsive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000010383 shanzha Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种具有润肠通便的复方制剂及其制备方法和应用,复方制剂的有效成分的重量配比如下:灵芝1~8份、牛蒡1~8份、黄精1~8份、黄秋葵1~8份、火龙果1~8份、无花果1~8份、紫薯1~8份、芡实0.5~8份、莲子0.5~8份、山药0.5~8份、茯苓0.5~8份、陈皮0.5~8份。本发明提供的具有润肠通便的复方制剂具有润肠通便的功能,能够有效促进人们通便、保证人们消化道健康,具有药效快、无毒副作用的优点,经过合理调配,制备方法改进,不仅具有润肠通便功效,还能满足人体基本的营养所需,口感极佳,适合日常食用。同时,本发明经过了临床实验验证,疗效显著,具有很好的应用价值及市场前景。
Description
技术领域
本发明涉及食品工程领域,特别指一种具有润肠通便的复方制剂及其制备方法和应用。
背景技术
随着现代人生活节奏的加快及饮食结构的改变,膳食纤维等促进肠道蠕动的食物摄入量减少,高蛋白食物摄入过多,加之体育锻炼减少,生活压力过大等因素,使得便秘逐渐成为令现代人困扰的常见病之一,发病率呈逐步升高的趋势,严重者可导致电解质和酸碱平衡紊乱,引起痔疮、下肢静脉曲张等疾病。已经严重影响了人们的生活质量和生命安全。便秘可以影响各年龄段的人。女性多于男性,老年多于青、壮年。便秘是临床上常见的慢性消化道疾病,通常以排便间隔延长,大便干结、艰涩不畅为主要症状,因便秘发病率高、病因复杂,患者常有许多苦恼,便秘严重时会影响生活质量,更容易引起多种并发症。长期的便秘可使肠道细菌发酵而产生的致癌物质刺激肠黏膜上皮细胞,导致异形增生,易诱发癌变。较硬的粪块阻塞肠腔使肠腔狭窄及压迫盆腔周围结构,阻碍了结肠蠕动,使直肠或结肠受压而造成血液循环障碍。便秘也可诱发肠道外的并发症,如脑卒中、影响大脑功能性生活障碍等。在肝性脑病、乳腺疾病、阿尔茨海默病等疾病的发生中也有重要的作用。临床上关于因便秘而用力增加腹压,屏气使劲排便造成的心血管疾病发作有逐年增多趋势,如诱发心绞痛,心肌梗死发作。
近年来人们的健康意识日益增强,市场上也陆续涌现出各式各样的润肠通便产品,但是有些方法(例如滥用泻药等)隐藏巨大危机,不仅不利于通便,长期滥用泻药会使肠道的敏感性减弱,形成对某些泻药的依赖性,造成便秘更加严重,而且还会损害身体健康。
发明内容
本发明提供一种具有润肠通便的复方制剂,包括如下重量配比的原料:灵芝1~8份、牛蒡1~8份、黄精1~8份、黄秋葵1~8份、火龙果1~8份、无花果1~8份、紫薯1~8份、芡实0.5~8份、莲子0.5~8份、山药0.5~8份、茯苓0.5~8份、陈皮0.5~8份。
进一步地,本发明提供一种具有润肠通便的复方制剂包括如下重量配比的原料:灵芝3~8份、牛蒡3~8份、黄精3~8份、黄秋葵3~8份、火龙果3~8份、无花果3~8份、紫薯3~8份、芡实1~5份、莲子1~5份、山药1~5份、茯苓1~5份、陈皮1~5份。
进一步地,所述的复方制剂为粉剂。
一种具有润肠通便的复方制剂的制备方法,包括如下制备步骤:
步骤一:将孔径为0.5μm~1μm的多孔陶瓷、灵芝、牛蒡、黄精和水混合,采用紫外线处理0.5h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
步骤二:将黄秋葵、火龙果、无花果、紫薯分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和水混匀;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
步骤三:将混合物M1和M2分别置于容器中采用乙醇进行喷淋处理后过滤,分别得到滤液L1和滤液L2;
步骤四:将步骤三得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,发酵1~3个月后,过滤去渣,得到滤液L11;
步骤五:将步骤三得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,发酵1~3个月后,过滤去渣,得到滤液L22;
步骤六:将上述步骤四和步骤五得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2;
步骤七:将芡实、莲子、山药、茯苓、陈皮粉碎成粉后过筛,得到粉末P3;
步骤八:将步骤六得到的两种酵素粉P1和P2与步骤七得到的粉末P3混合,即得到具有润肠通便的复方制剂。
进一步地,步骤三中,将混合物M1和M2分别置于真空容器中进行真空处理和乙醇喷淋处理后过滤,分别得到滤液L1和滤液L2。
进一步地,所述真空容器底部上侧设置有过滤网,所述真空容器内部顶端设置有乙醇溶液喷淋头,所述混合物M1或M2放置于所述过滤网上。
进一步地,采用的乙醇溶液浓度为60%~80%。
进一步地,纤维素酶和果胶酶的水解pH范围为4.0~5.5,温度范围为40~50℃,酶解5~10小时;蛋白酶和淀粉酶的水解pH范围为6.0~7.5,温度范围为35~45℃,酶解3~7小时。
一种如上任意所述具有润肠通便的复方制剂的制备方法所制备的具有润肠通便的复方制剂在润肠通便产品中的应用。
本发明提供的具有润肠通便的复方制剂具有润肠通便的功能,能够有效促进人们通便、保证人们消化道健康,具有药效快、无毒副作用的优点,经过合理调配,制备方法改进,不仅具有润肠通便功效,还能满足人体基本的营养所需,口感极佳,适合日常食用。同时,本发明经过了临床实验验证,疗效显著,具有很好的应用价值及市场前景。
具体实施方式
本发明提供一种具有润肠通便的复方制剂,包括如下重量配比的原料:灵芝1~8份、牛蒡1~8份、黄精1~8份、黄秋葵1~8份、火龙果1~8份、无花果1~8份、紫薯1~8份、芡实0.5~8份、莲子0.5~8份、山药0.5~8份、茯苓0.5~8份、陈皮0.5~8份。
优选地,本发明提供一种具有润肠通便的复方制剂包括如下重量配比的原料:灵芝3~8份、牛蒡3~8份、黄精3~8份、黄秋葵3~8份、火龙果3~8份、无花果3~8份、紫薯3~8份、芡实1~5份、莲子1~5份、山药1~5份、茯苓1~5份、陈皮1~5份。
本发明提供的具有润肠通便的复方制剂具有润肠通便的功能,能够有效促进人们通便、保证人们消化道健康,具有药效快、无毒副作用的优点,不仅具有润肠通便功效,还能满足人体基本的营养所需,口感极佳,适合日常食用。同时,本发明经过了临床实验验证,疗效显著,具有很好的应用价值及市场前景。
进一步地,所述的复方制剂为粉剂。
本发明还提供一种具有润肠通便的复方制剂的制备方法,包括如下制备步骤:
步骤一:将孔径为0.5μm~1μm的多孔陶瓷、灵芝、牛蒡、黄精和1~份水混合,采用紫外线处理0.5h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
步骤二:将黄秋葵、火龙果、无花果、紫薯分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和1~5份水混匀;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
步骤三:将混合物M1和M2分别置于容器中采用乙醇进行喷淋处理后过滤,分别得到滤液L1和滤液L2;
步骤四:将步骤三得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,发酵1~3个月后,过滤去渣,得到滤液L11;
步骤五:将步骤三得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,发酵1~3个月后,过滤去渣,得到滤液L22;
步骤六:将上述步骤四和步骤五得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2;
步骤七:将芡实、莲子、山药、茯苓、陈皮粉碎成粉后过筛,得到粉末P3;
步骤八:将步骤六得到的两种酵素粉P1和P2与步骤七得到的粉末P3混合,即得到具有润肠通便的复方制剂。
现有技术中对润肠通便复方制剂制备方法中,仅仅是将不同的原料进行简单粉碎混合后进行制剂。现有技术的制备方法不仅对原料中有效物质的提取效率低,且提取的有效物质也容易被降解,导致最终制备的产品效果不佳。此外在以上制备方法中,由于原料中会含有一定的霉菌,而采用现有技术制备方法所制备的产品往往难以进行长久保存,容易出现变质的现象。
本发明提供的制备方法采用紫外线处理不仅能够将原料中的细胞磨合细胞壁进行充分破坏,使原料中的有效成分更加充分地溶解出,且由于霉菌对紫外线较为敏感,因此霉菌能够在紫外线的处理下被有效将杀死。然而,在紫外线的照射下,原料中的有效物质将发生降解,从而使原料中有效物质的提取率降低。而在本发明中,针对不同的原料,加入孔径不同的多孔陶瓷。由于霉菌直径一般在2μm以上,而采用的多孔陶瓷小于2μm,霉菌无法进入多孔陶瓷内进行躲藏。因此,在本发明采用的技术方案,采用紫外线照射和酶解处理原料后,原料内的有效物质能够“躲进”多孔陶瓷内部,而不受到紫外线的影响,从而避免被降解,不仅有效提高了原料中细胞内物质的溶出率,还提高了细胞内溶出物质的有效物质提取率。
其中,采用不同孔径的多孔陶瓷是由于不同原料内的有效物质直径不同,一般地,这些有效物质大多为多糖以及其它物质。只有当被吸附物质直径小于且接近吸附载体的孔径时,才能确保被吸附物质被有效吸附且驻留于吸附载体内。本专利的发明人根据大量实验,得出了在对于黄秋葵、火龙果、无花果、紫薯采用孔径为1.0μm~1.5μm的多孔陶瓷,对于灵芝、牛蒡、黄精采用孔径为0.5μm~1μm的多孔陶瓷时,能够最有效地提取出原料中相应的有效物质。且经过提取出的有效物质进行组合,发挥其中的协同作用,才能够实现本专利申请提供的复方制剂显著的通便润肠作用。
在以上制备方法的基础上,进一步地,在步骤三中,将混合物M1和M2分别置于真空容器中进行真空处理和乙醇喷淋处理后过滤,分别得到滤液L1和滤液L2。其中,所述真空容器底部上侧设置有过滤网,所述真空容器内部顶端设置有乙醇溶液喷淋头,所述混合物M1或M2放置于所述过滤网上。混合物M1和混合物M2为多孔陶瓷、原料残渣和酶解液,由于原料中的大部分有效物质位于多孔陶瓷之中,将混合物M1和M2放置在过滤网上,采用真空处理能够将多孔陶瓷内的有效物质脱附出来,再采用乙醇进行喷淋,乙醇溶液在喷淋至多孔陶瓷中时,能够将原料中的有效物质萃取,再通过重力作用,流入真空容器底部,最后将真空容器底部的混合物过滤,分别得到滤液L1和滤液L2。
进一步地,采用的乙醇溶液浓度为60%~80%。该浓度的乙醇溶液能够对储存在多孔陶瓷中的有效物质进行最有效的提存萃取作用。
优选地,纤维素酶和果胶酶的水解pH范围为4.0~5.5,温度范围为40~50℃,酶解5~10小时;蛋白酶和淀粉酶的水解pH范围为6.0~7.5,温度范围为35~45℃,酶解时间为3~7小时。其中,淀粉酶为α-淀粉酶。
一种如上任意所述具有润肠通便的复方制剂的制备方法所制备的具有润肠通便的复方制剂在润肠通便产品中的应用。
其中,本发明选用的原料中:
灵芝,是多孔菌科真菌灵芝的子实体。灵芝药用在我国已有2000多年的历史,被历代医药家视为滋补强壮、扶正固本的神奇珍品。灵芝主含氨基酸、多肽、蛋白质、真菌溶菌酶,以及糖类(还原糖和多糖)、麦角甾醇、三萜类、香豆精甙、挥发油、硬脂酸、苯甲酸、生物碱、维生素B2及C等;孢子还含甘露醇、海藻糖。
黄精,性甘、平。归脾、肺、肾经。功效补气养阴,健脾,润肺,益肾。具有补脾,润肺生津的作用。
牛蒡,又名东洋参,牛蒡具有治疗糖尿病、高血压、高血脂、抗癌等作用。可降血糖、降血压、血脂、治疗失眠,提高人体免疫力等功效。
黄秋葵,美国人叫它“植物黄金金秋葵”,是降血糖的良药。黄秋葵根、叶、花均可药用:有清热解毒,消肿止痛,排脓生肌之功能。
火龙果,火龙果性甘平,主要营养成分有蛋白质、膳食纤维、维生素B2、维生素B3、维生素C、铁、磷、钙、镁、钾等。富含大量果肉纤维,有丰富的胡萝卜素,维他命B1、B2、B3、B12、C等。火龙果营养丰富、功能独特,它含有一般植物少有的植物性白蛋白以及花青素,丰富的维生素和水溶性膳食纤维。
无花果,健胃清肠,消肿解毒。治肠炎,痢疾,喉痛,痈疮疥癣,利咽喉,开胃驱虫。用于食欲不振,脘腹胀痛,痔疮便秘,消化不良,痔疮,脱肛,腹泻、乳汁不足,咽喉肿痛,热痢,咳嗽多痰等症。
紫薯,富含蛋白质、淀粉、果胶、纤维素、氨基酸、维生素及多种矿物质,同时还富含硒元素和花青素。紫薯营养丰富具特殊保健功能,其中的蛋白质氨基酸都是极易被人体消化和吸收的。紫薯在日本国家蔬菜癌症研究中心公布的抗癌蔬菜中名列榜首。
山药,甘,平归脾、肺、肾经。药用来源为薯蓣科植物山药干燥根茎。山药具有滋养强壮,助消化,敛虚汗,止泻之功效,主治脾虚腹泻、肺虚咳嗽、糖尿病消渴、小便短频、遗精、妇女带下及消化不良的慢性肠炎。山药的最大特点是含有大量的黏蛋白。黏蛋白是一种多糖蛋白质的混合物,对人体具有特殊的保健作用,能防止脂肪沈积在心血管上,保持血管弹性,阻止动脉粥样硬化过早发生;可减少皮下脂肪堆积;能防止结缔组织的萎缩,预防类风湿关节炎、硬皮病等胶原病的发生。
芡实,为睡莲科植物芡的干燥成熟种仁。味甘、涩,性平。归脾、肾经。主要功效益肾固精,补脾止泻。
莲子,为睡莲科植物莲的干燥成熟种子。味甘、涩,性平。归脾、肾、心经。功效补脾止泻,止带,益肾涩精,养心安神。用于脾虚泄泻,带下,遗精,心悸失眠。
陈皮,味苦、辛,性温。归肺、脾经。理气健脾,燥湿化痰。与山楂、神曲等同用,用于食积气滞,脘腹胀痛者。
下面结合具体实施例子对本发明做进一步的详细描述。
实施例1
本发明一种具有润肠通便的复方制剂的制备方法,具体操作步骤如下:
取灵芝6份、黄精8份、牛蒡8份打碎后与孔径为0.5μm~1μm的多孔陶瓷和2份水混合,采用紫外线处理0.8h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
取黄秋葵8份、火龙果7份、无花果7份、紫薯8份分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和2份水混匀;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
将混合物M1和M2分别置于真空容器中进行真空处理和采用60%浓度的乙醇进行喷淋处理1.0h后过滤,分别得到滤液L1和滤液L2;
将得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L11;
将得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L22;
将得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2,备用;
将6份芡实、6份莲子、8份山药、8份茯苓、7份陈皮粉碎后成粉过筛,得到粉末P3,备用;
将得到的两种酵素粉P1和P2与得到的粉末P3混合均匀,即得到具有润肠通便的复方制剂。
实施例2
本发明一种具有润肠通便的复方制剂的制备方法,具体操作步骤如下:
取灵芝2份、黄精1份、牛蒡1份打碎后与孔径为0.5μm~1μm的多孔陶瓷和1份水混合,采用紫外线处理0.8h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
取黄秋葵2份、火龙果1份、无花果1份、紫薯2份分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和1份水混匀;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
将混合物M1和M2分别置于真空容器中进行真空处理和采用80%浓度的乙醇进行喷淋处理1.0h后过滤,分别得到滤液L1和滤液L2;
将得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L11;
将得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L22;
将得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2,备用;
将0.5份芡实、1份莲子、1份山药、0.5份茯苓、0.5份陈皮粉碎后成粉过筛,得到粉末P3,备用;
将得到的两种酵素粉P1和P2与得到的粉末P3混合均匀,即得到具有润肠通便的复方制剂。
实施例3
本发明一种具有润肠通便的复方制剂的制备方法,具体操作步骤如下:
取灵芝5份、黄精5份、牛蒡5份打碎后与孔径为0.5μm~1μm的多孔陶瓷和2份水混合,采用紫外线处理0.8h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
取黄秋葵8份、火龙果8份、无花果8份、紫薯8份分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和2份水混匀;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
将混合物M1和M2分别置于真空容器中进行真空处理和采用75%浓度的乙醇进行喷淋处理1.0h后过滤,分别得到滤液L1和滤液L2;
将得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L11;
将得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L22;
将得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2,备用;
将5份芡实、6份莲子、5份山药、4份茯苓、5份陈皮粉碎后成粉过筛,得到粉末P3,备用;
将得到的两种酵素粉P1和P2与得到的粉末P3混合均匀,即得到具有润肠通便的复方制剂。
实施例4
本发明一种具有润肠通便的复方制剂的制备方法,具体操作步骤如下:
取灵芝5份、黄精5份、牛蒡5份打碎后与孔径为0.5μm~1μm的多孔陶瓷和2份水混合,采用紫外线处理0.8h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
取黄秋葵8份、火龙果8份、无花果8份、紫薯8份分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和2份水混匀;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
将混合物M1和M2分别置于容器中采用75%浓度的乙醇进行喷淋处理1.0h后过滤,分别得到滤液L1和滤液L2;
将得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L22;
将得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2,备用;
将5份芡实、6份莲子、5份山药、4份茯苓、5份陈皮粉碎后成粉过筛,得到粉末P3,备用;
将得到的两种酵素粉P1和P2与得到的粉末P3混合均匀,即得到实施例4。
对比例1
取黄秋葵8份、火龙果8份、无花果8份、紫薯8份分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和2份水混匀;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
将混合物M2分别置于真空容器中进行真空处理和采用75%浓度的乙醇进行喷淋处理1.0h后过滤,分别得到滤液L2;
将得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L22;
将得到的滤液L22分别采用喷雾干燥,制成酵素粉P2,备用;
将5份芡实、6份莲子、5份山药、4份茯苓、5份陈皮粉碎后成粉过筛,得到粉末P3,备用;
将得到的两种酵素粉P2与得到的粉末P3混合均匀,即得到对比例1。
对比例2
取灵芝5份、黄精5份、牛蒡5份打碎后与孔径为0.5μm~1μm的多孔陶瓷和2份水混合,采用紫外线处理0.8h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
取黄秋葵8份、火龙果8份、无花果8份、紫薯8份分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和2份水混匀;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
将混合物M1和M2分别置于真空容器中进行真空处理和采用75%浓度的乙醇进行喷淋处理1.0h后过滤,分别得到滤液L1和滤液L2;
将得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L11;
将得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L22;
将得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2,备用;
将得到的两种酵素粉P1和P2混合均匀,即得到对比例2。
对比例3
取灵芝5份、黄精5份、牛蒡5份打碎后与孔径为0.5μm~1μm的多孔陶瓷和2份水混合,采用紫外线处理0.8h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
将混合物M1置于真空容器中进行真空处理和采用75%浓度的乙醇进行喷淋处理1.0h后过滤,得到滤液L1;
将得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L11;
将得到的滤液L11采用喷雾干燥,制成酵素粉P1,备用;
将5份芡实、6份莲子、5份山药、4份茯苓、5份陈皮粉碎后成粉过筛,得到粉末P3,备用;
将得到的两种酵素粉P1和与得到的粉末P3混合均匀,即得到具有润肠通便的复方制剂。
对比例4
本发明一种具有润肠通便的复方制剂的制备方法,具体操作步骤如下:
取灵芝5份、黄精5份、牛蒡5份打碎后和2份水混合,采用紫外线处理0.8h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
取黄秋葵8份、火龙果8份、无花果8份、紫薯8份分别洗净,打碎,混匀;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
将混合物M1和M2分别置于真空容器中进行真空处理和乙醇进行喷淋处理1.0h后过滤,分别得到滤液L1和滤液L2;
将得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L11;
将得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,混合均匀,发酵2个月后,过滤去渣,得到滤液L22;
将得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2,备用;
将5份芡实、6份莲子、5份山药、4份茯苓、5份陈皮粉碎后成粉过筛,得到粉末P3,备用;
将得到的两种酵素粉P1和P2与得到的粉末P3混合均匀,即得到具有润肠通便的复方制剂。
采用本发明实施例制备的具有润肠通便的复方制剂以及对比例制备的制剂测试对小鼠小肠推进运动和排便的影响,测试实验如下:
选用雄性成年小鼠,分为两组分别进行小肠推进实验和排便实验,小鼠体重相近,均为20g~24g,随机分为模型对照组、阴性对照组、实验组1、实验组2、实验组3和实验组4、对照组1、对照组2、对照组3、对照组4,每组10只小鼠。其中实验组1早晚用上述实施例1制备的粉剂(取粉,加纯净水搅拌溶解),实验组2早晚用上述实施例2制备的粉剂(取粉,加纯净水搅拌溶解),实验组3早晚用上述实施例3制备的粉剂(取粉,加纯净水搅拌溶解),实验组4早晚用上述实施例4制备的粉剂(取粉,加纯净水搅拌溶解),对照组1早晚用上述对比例1制备的粉剂(取粉,加纯净水搅拌溶解),对照组2早晚用上述对比例2制备的粉剂(取粉,加纯净水搅拌溶解),对照组3早晚用上述对比例3制备的粉剂(取粉,加纯净水搅拌溶解),对照组4早晚用上述对比例4制备的粉剂(取粉,加纯净水搅拌溶解)。模型对照组和阴性对照组给予与粉剂溶液等量的蒸馏水,每天分两次给予,连续灌胃10天,观察小鼠小肠推进实验和排便实验。其中,各组小鼠喂用的粉剂用量一样,且小鼠所处的环境稳定且一致,室温均为25℃±2℃,湿度为80%±3%。
小鼠小肠推进运动的影响:
各组小鼠连续灌胃给予受试物10d,最后一次灌胃实验前各组小鼠禁食16h,禁食后,模型对照组、实验组和对照组均灌胃给予5mg/(kg·BW)复方地酚诺酯溶液20mL/(kg·BW),阴性对照组给予等量蒸馏水,30min后,各组小鼠均一次给予含相应受试物(1∶1混合)的墨汁10mL/(kg·BW),模型对照组和阴性对照组给予等量墨汁。5min后颈椎脱臼处死动物,立即打开腹腔分离肠系膜,剪取上端自幽门、下端至回盲部的肠管,不加牵引拉成直线,进行测量。肠管长度为“小肠总长度”,从幽门至墨汁前沿为“墨汁推进长度”。按下列公式计算墨汁推进率:
墨汁推进率=墨汁推进长度/小肠总长度×100%。
测试结果如表1所示:
表1
组别 | 动物数/只 | 墨汁推进距离/cm | 肠管总长度/cm | 墨汁推进率/% |
实验组1 | 10 | 25.18±1.21 | 30.75±2.82 | 81.88±4.93 |
实验组2 | 10 | 24.05±1.69 | 31.85±2.73 | 75.51±6.24 |
实验组3 | 10 | 25.51±1.33 | 32.05±2.95 | 79.59±5.20 |
实验组4 | 10 | 20.98±1.86 | 31.55±3.35 | 66.50±5.95 |
对照组1 | 10 | 15.98±1.47 | 30.98±3.11 | 51.58±4.87 |
对照组2 | 10 | 16.17±1.35 | 31.25±2.55 | 51.74±5.02 |
对照组3 | 10 | 17.71±1.06 | 31.58±2.46 | 56.07±4.96 |
对照组4 | 10 | 18.98±1.86 | 32.87±3.02 | 57.74±4.11 |
模型对照 | 10 | 14.14±2.09 | 32.44±3.17 | 43.58±5.36 |
阴性对照 | 10 | 24.01±3.05 | 31.08±2.68 | 77.25±10.13 |
由表1可知,实验组1~3的墨汁推进率在75%以上与模型对照组的43.58%±5.36%相比,墨汁推进率具有显著提高;而对照组1~3与实验组3相比,分别相应缺少了部分原料配方组成,而实验结果显示墨汁推进率不到60%,可以得出,本专利申请各组分之间发生了一定的协同作用,才达到了原料中各单一组分或部分组分组合所无法达到的显著效果;而实验组4与实验组3相比,实验组4中没有采用真空进行处理,墨汁推进率略有下降,但仍比模型对照组和对照组1~3高,可知真空处理能够将多孔陶瓷内的有效物质进行充分脱附,进而使最后制得的粉剂有着显著的促进小肠运动的作用;对照组与实验组3相比,对照组4中并未加入多孔陶瓷,墨汁推进率仅为57.74%±4.11%,且通过显微观察实验组中的多孔陶瓷,可以看到堵控陶瓷内贮藏有丰富的有效物质,可以得知,实验组中加入的多孔陶瓷确实有效地保护了原料中的有效物质,并被最终提出出来。
通过以上筛选实验,可以看出,正是本发明实施例中提供的各种原料结合其制备工艺,使原料中的各组分之间发挥了优异协同作用,使制得的复方制剂能够明显促进小肠运动,并具有显著的润肠通便作用。
小鼠排便的影响:
各组小鼠连续灌胃给予受试物10d,最后一次灌胃实验前各组小鼠禁食16h,禁食后,模型对照组、实验组和对照组均灌胃给予10mg/(kg·BW)复方地酚诺酯溶液20mL/(kg·BW),阴性对照组给予等量蒸馏水,30min后,各组小鼠均一次给予含相应受试物(1∶1混合)的墨汁10mL/(kg·BW),模型对照组和阴性对照组给予等量墨汁。同时开始计时,每只动物均单独饲养,并供给饲料和饮水,观察记录每只动物首次排黑便所需时间、6h内排黑便粒数及重量,实验结果如表2所示:
表2
组别 | 动物数/只 | 首便时间/min | 粪便粒数/只 | 粪便重量g/粒 |
实验组1 | 10 | 106.56±9.83 | 21±3 | 0.61±0.17 |
实验组2 | 10 | 112.05±11.56 | 18±2 | 0.57±0.15 |
实验组3 | 10 | 108.23±8.26 | 19±3 | 0.55±0.16 |
实验组4 | 10 | 121.56±22.01 | 15±4 | 0.35±0.12 |
对照组1 | 10 | 190.46±18.63 | 10±3 | 0.41±0.14 |
对照组2 | 10 | 198.23±16.54 | 9±4 | 0.38±0.11 |
对照组3 | 10 | 150.44±19.42 | 13±4 | 0.39±0.10 |
对照组4 | 10 | 159.15±17.01 | 12±3 | 0.40±0.16 |
模型对照 | 10 | 223.61±34.36 | 7±2 | 0.35±0.15 |
阴性对照 | 10 | 92.44±47.20 | 23.±6 | 0.65±0.21 |
由表2可见,实验组1~3与模型对照组相比,小鼠的首便时间能够显著缩短,每只小鼠粪便粒数有所增加,每粒粪便的重量也有所增重;而对照组1~3与实验组3相比,分别相应缺少了部分原料配方组成,而实验结果显示,首便时间、每只小鼠粪便粒数以及每粒粪便的重量虽然较模型对照组有所提升,但仍远不及实验组1~4的效果显著,可以得出,本专利申请各组分之间发生了一定的协同作用,才达到了原料中各单一组分或部分组分组合所无法达到的显著效果;而实验组4和对照组4与实验组3相比,其它条件相同,实验组4中没有采用真空进行处理,首便时间、每只小鼠粪便粒数以及每粒粪便的重量有所下降,可知真空处理能够将多孔陶瓷内原料的有效物质进行充分脱附,进而使最后制得的粉剂有着显著的促进小肠运动的作用;其它条件相同,而对照组4中并未加入多孔陶瓷,首便时间、每只小鼠粪便粒数以及每粒粪便的重量也未及实验组3,实验组中加入的多孔陶瓷确实有效地保护了原料中的有效物质,并被最终提出出来。通过以上筛选实验,可以看出,正是本发明实施例中提供的各种原料结合其制备工艺,使原料中的各组分之间发挥了优异协同作用,使制得的复方制剂能够明显促进小肠运动,并具有显著的润肠通便作用。
将相同质量的本发明实施例1~3制备的具有润肠通便的复方制剂和对比例5(原料与对比例2一致,采用现有技术将原料简单粉碎混合后制得粉剂),在28℃±1℃下放入相同的马铃薯-葡萄糖-琼脂培养基中,并将培养基置于无菌环境中静置,保持空气流通,分别在7天、14天、和21天观察培养基内的霉菌数(CFU/g);其中一组培养基不加入试剂,其它条件一致,进行空白参照实验,实验结果如表3所示:
表3
时间 | 实施例1 | 实施例2 | 实施例3 | 实施例5 | 空白对照 |
7天 | 8CFU/g | 6CFU/g | 5CFU/g | 21CFU/g | 4CFU/g |
14天 | 15CFU/g | 12CFU/g | 10CFU/g | 72CFU/g | 10CFU/g |
21天 | 20CFU/g | 21CFU/g | 24CFU/g | 102CFU/g | 16CFU/g |
由表3可以看出本发明实施例制备的具有润肠通便的复方制剂与现有制备工艺制备的复方制剂相比,霉菌含量少,因此能够更加长久保存,与现有技术相比具有显著的进步和巨大的市场前景。
上述仅为本发明的具体实施方式,但本发明的设计构思并不局限于此,凡利用此构思对本发明进行非实质性的改动,均应属于侵犯本发明保护范围的行为。
最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。
Claims (8)
1.一种具有润肠通便的复方制剂,其特征在于,由如下重量配比的原料组成:灵芝1~8份、牛蒡1~8份、黄精1~8份、黄秋葵1~8份、火龙果1~8份、无花果1~8份、紫薯1~8份、芡实0.5~8份、莲子0.5~8份、山药0.5~8份、茯苓0.5~8份、陈皮0.5~8份;
包括如下制备步骤:
步骤一:将孔径为0.5μm~1μm的多孔陶瓷、灵芝、牛蒡、黄精和水混合,采用紫外线处理0.5h~1.0h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
步骤二:将黄秋葵、火龙果、无花果、紫薯分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和水混合;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
步骤三:将混合物M1和M2分别置于真空容器中进行真空处理和乙醇喷淋处理后过滤,分别得到滤液L1和滤液L2;
步骤四:将步骤三得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,发酵1~3个月后,过滤去渣,得到滤液L11;
步骤五:将步骤三得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,发酵1~3个月后,过滤去渣,得到滤液L22;
步骤六:将上述步骤四和步骤五得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2;
步骤七:将芡实、莲子、山药、茯苓、陈皮粉碎成粉后过筛,得到粉末P3;
步骤八:将步骤六得到的两种酵素粉P1和P2与步骤七得到的粉末P3混合,即得到具有润肠通便的复方制剂。
2.如权利要求1所述的一种具有润肠通便的复方制剂,其特征在于,包括如下重量配比的原料:灵芝3~8份、牛蒡3~8份、黄精3~8份、黄秋葵3~8份、火龙果3~8份、无花果3~8份、紫薯3~8份、芡实1~5份、莲子1~5份、山药1~5份、茯苓1~5份、陈皮1~5份。
3.如权利要求1或2所述的一种具有润肠通便的复方制剂,其特征在于:所述的复方制剂为粉剂。
4.一种权利要求1或2所述的具有润肠通便的复方制剂的制备方法,其特征在于,包括如下制备步骤:
步骤一:将孔径为0.5μm~1μm的多孔陶瓷、灵芝、牛蒡、黄精和水混合,采用紫外线处理0.5h~1.0h后,加入纤维素酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M1;
步骤二:将黄秋葵、火龙果、无花果、紫薯分别洗净,打碎,与孔径为1.0μm~1.5μm的多孔陶瓷和水混合;采用紫外线处理0.5h后,加入纤维素酶和果胶酶进行酶解,接着再加入蛋白酶和淀粉酶进行酶解,得到混合物M2;
步骤三:将混合物M1和M2分别置于真空容器中进行真空处理和乙醇喷淋处理后过滤,分别得到滤液L1和滤液L2;
步骤四:将步骤三得到的滤液L1置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,发酵1~3个月后,过滤去渣,得到滤液L11;
步骤五:将步骤三得到的滤液L2置于密闭发酵罐中,加入蔗糖,再加入酵母菌和乳酸菌,发酵1~3个月后,过滤去渣,得到滤液L22;
步骤六:将上述步骤四和步骤五得到的滤液L11和滤液L22分别采用喷雾干燥,制成酵素粉P1和P2;
步骤七:将芡实、莲子、山药、茯苓、陈皮粉碎成粉后过筛,得到粉末P3;
步骤八:将步骤六得到的两种酵素粉P1和P2与步骤七得到的粉末P3混合,即得到具有润肠通便的复方制剂。
5.根据权利要求4所述的一种具有润肠通便的复方制剂的制备方法,其特征在于:所述真空容器底部上侧设置有过滤网,所述真空容器内部顶端设置有乙醇溶液喷淋头,所述混合物M1或M2放置于所述过滤网上。
6.根据权利要求4所述的一种具有润肠通便的复方制剂的制备方法,其特征在于:采用的乙醇溶液浓度为60%~80%。
7.根据权利要求4所述的一种具有润肠通便的复方制剂的制备方法,其特征在于:纤维素酶和果胶酶的水解pH范围为4.0~5.5,温度范围为40~50℃,酶解5~10小时;蛋白酶和淀粉酶的水解pH范围为6.0~7.5,温度范围为35~45℃,酶解3~7小时。
8.一种根据权利要求4~7任一项所述具有润肠通便的复方制剂的制备方法所制备的具有润肠通便的复方制剂在制备润肠通便产品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710764720.9A CN107375697B (zh) | 2017-08-30 | 2017-08-30 | 一种具有润肠通便的复方制剂及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710764720.9A CN107375697B (zh) | 2017-08-30 | 2017-08-30 | 一种具有润肠通便的复方制剂及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107375697A CN107375697A (zh) | 2017-11-24 |
CN107375697B true CN107375697B (zh) | 2021-06-29 |
Family
ID=60348874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710764720.9A Active CN107375697B (zh) | 2017-08-30 | 2017-08-30 | 一种具有润肠通便的复方制剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107375697B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112515089A (zh) * | 2019-09-18 | 2021-03-19 | 东北农业大学 | 一种去火降燥的代餐粉及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB191125879A (en) * | 1910-12-05 | 1912-11-20 | Hanuemon Yenjo | Process of Producing Digestive Ferment. |
CN1215561A (zh) * | 1997-10-27 | 1999-05-05 | 邢文海 | 保健茶 |
CN1772164A (zh) * | 2005-10-26 | 2006-05-17 | 柴伟利 | 一种治疗慢性便秘的药物 |
CN102319342A (zh) * | 2011-10-14 | 2012-01-18 | 贵州明湖药业股份有限公司 | 一种润肠通便的药物及其制备方法 |
CN106072596A (zh) * | 2016-07-26 | 2016-11-09 | 厦门益力康生物科技有限公司 | 一种促消化酵素及其制备方法 |
-
2017
- 2017-08-30 CN CN201710764720.9A patent/CN107375697B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB191125879A (en) * | 1910-12-05 | 1912-11-20 | Hanuemon Yenjo | Process of Producing Digestive Ferment. |
CN1215561A (zh) * | 1997-10-27 | 1999-05-05 | 邢文海 | 保健茶 |
CN1772164A (zh) * | 2005-10-26 | 2006-05-17 | 柴伟利 | 一种治疗慢性便秘的药物 |
CN102319342A (zh) * | 2011-10-14 | 2012-01-18 | 贵州明湖药业股份有限公司 | 一种润肠通便的药物及其制备方法 |
CN106072596A (zh) * | 2016-07-26 | 2016-11-09 | 厦门益力康生物科技有限公司 | 一种促消化酵素及其制备方法 |
Non-Patent Citations (1)
Title |
---|
食用型酵素产品的研究进展;敖梅英等;《安徽农业科学》;20161231;第44卷(第30期);第64页2.1段及65页3.1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN107375697A (zh) | 2017-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100937455B1 (ko) | 차전자피, 미강발효추출물 및 효모추출물이 함유된 배변촉진용 식품 및 이의 제조방법 | |
CN104351586A (zh) | 一种牛配合饲料及其制备方法 | |
KR101646156B1 (ko) | 숙변 제거 효능이 있는 장 기능 개선 발효식품 및 그 제조방법 | |
CN104351587A (zh) | 一种牛饲料及其制备方法 | |
CN106954843A (zh) | 一种复合植物酵素原液、功能性复合植物酵素原液及其制备方法和功能性食品 | |
CN103110861A (zh) | 一种预防婴幼儿上火调节肠胃的颗粒剂及其制备方法 | |
CN112618691A (zh) | 一种具有补气血功效的中药组合物及其制备方法和应用 | |
KR20170072003A (ko) | 흰찰쌀보리를 이용한 당뇨에 도움을 주는 발효식품 제조방법 및 그에 의해 제조된 발효식품 | |
KR20160119999A (ko) | 동의보감 원문에 근거한 국산 유기농 공진단 및 이의 제조방법 | |
CN106389784A (zh) | 清肺润肺、增强免疫力的组合物及其应用 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN107375697B (zh) | 一种具有润肠通便的复方制剂及其制备方法和应用 | |
CN111387345A (zh) | 一种复合多糖组合物及其制备方法 | |
KR20180000874A (ko) | 미세먼지 및 중금속과 항생물질 분해 배출에 도움을 주는 영양식품 조성물 및 이를 제조하는 방법 | |
CN104719906B (zh) | 含毛葱活性成分的健康食品及其生产方法 | |
CN114470084A (zh) | 环保高效防治罗非鱼白便的组合物及其制备方法和应用 | |
CN107308248A (zh) | 一种益于提高畜禽生产性能的中草药复方制剂及其制备方法和使用方法 | |
CN104188021B (zh) | 绿豆解毒保肝健康饮品及其生产方法 | |
CN103263538B (zh) | 对畜禽滋补消炎止泻止血止痛的中药组合物及制备方法 | |
CN107467654B (zh) | 一种海带海参复合提取物及其制备方法和应用 | |
CN106376792A (zh) | 一种黑木耳清肺粉及其制备方法 | |
CN108902731A (zh) | 一种健脾养胃、促进儿童智力发育及身体成长的面条及其制备方法 | |
CN109588551A (zh) | 一种治疗代谢病的饲料添加剂及其制备方法 | |
CN112957386B (zh) | 一种中药饮片的炮制方法 | |
CN112972631B (zh) | 具有改善胃健康、调节肠道菌群功能的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |